Connect with us

Business

How Recent Results from Aurora Cannabis Inc (OTCMKTS:ACBFF) Suggest Bigger Things to Come

Published

on

Aurora Cannabis Inc (OTCMKTS:ACBFF) continues to be a clear market leader in terms of raw access to growth in the Canadian cannabis sector as we approach the full adult-use legalization date later this month. This was again on display last week as the company hit the tape with its latest quarterly report.

“Aurora made substantial progress toward our strategic goal of becoming the global scale and margin leader in the cannabis industry, establishing a vertically integrated company with a broadly diversified product offering with a large global footprint,” said Terry Booth, CEO of Aurora. “Our high-pace, consistent execution has enabled us to complete a number of transformative acquisitions, bringing together industry-leading companies in terms of scale, quality, efficiencies, plant and medical science, product development and innovation, brands, and international distribution.”

Aurora Cannabis Inc (OTCMKTS:ACBFF) is one of the most widely diversified players in the cannabis space due to its powerful strategic investments.

In addition to the Company’s rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies – MedReleaf, CanvasRX, Peloton Pharmaceutical,  Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending acquisition of ICC Labs – Aurora is distinguished by its reputation as a partner of choice and employer of choice in the global cannabis sector.

The company has invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD), Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste Technologies Inc. (TSXV: N), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).

However, just drilling down into its core cannabis production operations, through Aurora Cannabis Enterprises Inc, trumpets itself as “one of the world’s largest and leading cannabis companies” and a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR).

The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, known as Aurora Mountain, is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal’s West Island.

Aurora Cannabis Inc (OTCMKTS:ACBFF) is pulling in trailing 12-month revenues of $42M, with revenues of $19.2 million for the quarter ended June 30, which is up 223% compared to the same period in 2017. In addition, the company is sitting on a mountain of assets, with its latest data showing over $167 million on the balance sheet against just $57M in debt.

 

Aces Up

As discussed above, ACBFF shares continue to benefit from the company’s growth along with its extremely rich and diversified base of strategic investments.

Mr. Booth added, “With coast-to-coast supply arrangements, and our strategic investment in Alcanna, we are very well positioned to capitalize on the significant adult consumer use opportunity in Canada. With reported Q4 revenues of $19.1 million, pro-forma Q4 revenues of over $33.1 million, and production capacity scaling up rapidly, we anticipate accelerated revenue growth during fiscal 2019. We have invested heavily in our organizational capabilities, including sales, marketing, and corporate talent and capacity, to ensure we will continue to drive strong and sustainable long-term growth.”

The stock has been very strong since securing technical support back in early August when shares briefly dipped down under the $5/share level for a few days. When that level was retaken by bulls, it was truly off to the races, and this quarterly report helps to explain why.

Mr. Booth concluded, “Today, Aurora ticks all the boxes for sustainable success and leadership in the cannabis industry. Aurora is capitalizing on a once in a lifetime opportunity, and establishing new industry standards in terms of execution, science, cultivation, international expansion and product development that position us exceptionally well to do so. We are very proud of our achievements over the past year, and we look forward to fiscal 2019 as we continue to execute.”

Business

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Subsidiary’s Cannabis Product Performs Remarkably

Published

on

By

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is an industry leader in the development of cannabinoid-based therapies. Some of this company’s leading products help treat a wide range of medical disorders and conditions.

Nature of the research

This company’s subsidiary, One World Cannabis, has been researching its Medical Grade Cannabis. It has unveiled the results of the research terming them Top Line. This was a single-dose, randomized, crossover study that sought to compare several aspects of the medical solutions. Among them included the safety, tolerability, and pharmacokinetics (PK) of the buccal Sativex® versus the Orally Disintegrating Tablets (MGC-ODT). Some of the elements to be studied include THC, THC metabolite 11-hydroxy-THC, and CBD. An official working with OWC Pharmaceutical Research Corp says that the research involved some healthy adult volunteers.

This research was conducted at the Sourasky Medical Center, which is situated in Tel Aviv. The study will help deliver top-notch products to consumers on a nationwide scale and even beyond borders.

One of the lede researchers reveals that the persons participating in the study were administered randomly. As outlined earlier, the products in question were OWC-ODT (4.2 mg THC, 5 mg CBD) and Sativex (5.4 mg THC, 5.0 mg CBD). The study also involved a two weeks cross over period.

Results of the study

 The researcher also revealed that after 24 hours of the product administration, plasma would be collected from the volunteers. The other thing would be to monitor the effects of the products, and then the researchers would go to the next step. Probably, that would be the checking out as well as the quantification of the THC, CBD, and 11-OH-THC concentrations. The determination of the plasma PK will be important in writing down the final report.

The TLR indicates that both the administration of both MGC-ODT and Sativex® pulled along with rather similar mean times. This was specifically in terms of half-life, peak concentration, and eventually, the elimination rates.

One unique aspect of the results is how they showed some dose-related comparability for the products in terms of bioavailability and absorption. Another important point worth noting is that the treatment incidence showed the related adverse events (AEs), indicating a lot of similarities between the administered treatments.

Continue Reading

Business

Glance Technologies Inc (OTCMKTS:GLNNF) Communicates To Shareholder Through A Letter

Published

on

Glance Technologies Inc (OTCMKTS:GLNNF) owns the dynamic mobile payment and loyalty technology platform known as Glance Pay®. Today, the CEO of the company Jonathan Hoyles has written a letter to the shareholder in the company. This is the first letter the official is writing to them in the position of the company’s Interim CEO.

Hoyles and his words for shareholders

Hoyles wants all shareholders to understand everything regarding the operations and plans. Through this letter, shareholders get to understand what the company intends to over the coming six to twelve months.

The company’s CEO discloses that a short while back, they set some clear measures and goals to help the company move forward. The target is to achieve the set goals within a short time. Some analysts that have had the opportunity to read through these goals see them as overly ambitious.

However, Hoyles exudes confidence saying that they have a dependable team in place. According to the official, this is crucial towards the achievement of the company’s set goals. The leader is quick to admit that indeed, progress is a matter that calls for a company’s dedication to taking the necessary risks. He urges everyone, including the shareholders, in the company, to give their support so that they achieve a home run.

Research and developmental plans

In recent times, the company has directed some funds into quantitative and qualitative market research. Some of the activities it has found helpful include merchant interviews, end-user surveys, and external research. One thing coming out pretty clearly is the fact that most of the end-users seek to be rewarded for their continued loyalty to the company and its diverse products.

Asides from this, they are calling out to the company to move with speed in setting up more restaurant locations for them. It is worth noting that users greatly appreciate the company’s support in helping them pay bills easily and quickly. However, the company thinks it needs to do more than offer them convenience. It wants to move a step further to give them suggestions on items that they need to try out.

Further improvements will be made in marketing and branding, sales and distribution, and also in the enhancement of customer experience. Howles says that they will focus on the right priorities. To him, the best thing is for the company to move its resources to areas of greater yield and productivity.

Continue Reading

Business

Green Organic Dutchman Holdings (OTCMKTS:TGODF) To Review Financing Alternatives For Construction Purposes

Published

on

Green Organic Dutchman Holdings (OTCMKTS:TGODF) has, over the years, been focusing on the production of premium organic cannabis products. The business guru has today disclosed details about its credit financing. According to its spokesperson, the company needs to complete the construction of a number of its business facilities. The facilities are in Ontario, Ancaster, and Phase 1a at Valleyfield, Quebec. Lately, the business has been reviewing some financial alternatives to see the ones to settle for.

The turn of events

In a statement, the company has revealed that the market conditions have been very dynamic and thus need from proper planning. It has, in the past, held discussions regarding some commercial bank facilities and equipment leasing in a bid to identify what would work. The company admits that the discussions were fruitful since it was able to chart the way forward. However, the main point of the discussion wasn’t arrived at. That was because most of the financing sources turned out to be inappropriate. The company says that most of them did not match the required timeframes. It says it had no otherwise but to start reviewing other alternatives.

Plans moving forward

The completion of these facilities is a costly undertaking, but the company seems quite determined.

An official working with The Green Organic Dutchman Holdings but who wanted his identity kept anonymous has made a point. He says that the company, at the moment, has no debt. However, it has about $56.7 million available in cash in Canada. It also has some $40.2 million that will take care of the company’s capital expenditures. The construction activities at the Ancaster are almost reaching completion according to sources. The business giant says that in a matter of about 6-weeks, it will have completed the construction activities here.

Green Organic Dutchman Holdings is optimistic it will get the financing that it requires. In that particular regard, it will channel the funds towards accelerating its commercial production. The goal is to increase its revenues by a significant margin.

So far, the company has gotten into several supply agreements. Some of them are with Alberta, British Columbia, and Ontario. The deal is to engage in the distribution of products on a nationwide scale.

Continue Reading
Advertisement

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade


FEATURED STORIES

Business20 hours ago

OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) Subsidiary’s Cannabis Product Performs Remarkably

Post Views: 167 OWC Pharmaceutical Research Corp (OTCMKTS:OWCP) is an industry leader in the development of cannabinoid-based therapies. Some of...

Business20 hours ago

Glance Technologies Inc (OTCMKTS:GLNNF) Communicates To Shareholder Through A Letter

Post Views: 66 Glance Technologies Inc (OTCMKTS:GLNNF) owns the dynamic mobile payment and loyalty technology platform known as Glance Pay®....

Business2 days ago

Green Organic Dutchman Holdings (OTCMKTS:TGODF) To Review Financing Alternatives For Construction Purposes

Post Views: 138 Green Organic Dutchman Holdings (OTCMKTS:TGODF) has, over the years, been focusing on the production of premium organic...

Business2 days ago

HEXO (OTCMKTS:HYYWF) Expects To Post Net Revenues Of $16.5 Million in Q4 2019 And $48.5 Million For FY 2019

Post Views: 133 HEXO (OTCMKTS:HYYWF) expects to post net revenues of up to $16.5 million in Q4 2019. The company...

Business5 days ago

LeafBuyer Technologies Inc. (OTCMKT:LBUY) Reports 59% YoY Growth In Revenue Following Optimization Of Its Platforms

Post Views: 218 LeafBuyer Technologies Inc. (OTCMKT:LBUY) has announced that its annual revenue for FY 2019 grew by 59%, reflecting...

Business5 days ago

High Tide Inc. (OTCMKTS:HITIF) Report Impressive Q3 Financial Results with Revenue Growing 281%

Post Views: 171 High Tide Inc. (OTCMKTS:HITIF) has announced an inspiring financial result for its third quarter of 2019. The...

Business6 days ago

Kalytera Therapeutics Inc (OTCMKTS:KALTF) Provides Details About Its Latest Notice Of Allowance

Post Views: 155 Kalytera Therapeutics Inc (OTCMKTS:KALTF) has today revealed details regarding the EU Patent Application Number 14791611.8. According to...

Business6 days ago

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Engages Cellular Biologist David A. Judd In An Interview

Post Views: 834 Pharmacyte Biotech Inc (OTCMKTS:PMCB) uses its live-cell encapsulation technology known as Cell-in-a-Box®  for the treatment of diabetes...

Business7 days ago

CV Sciences Inc (OTCMKTS:CVSI) enters a Distribution Agreement With Harris Teeter

Post Views: 149 CV Sciences Inc (OTCMKTS:CVSI) today announced its business collaboration with Harris Teeter. These two business giants target...

Business7 days ago

Tetra Bio Pharma Inc (OTCMKTS:TBPMF) Speaks Out On Its CAUMZ(TM) Kit

Post Views: 159 Tetra Bio Pharma Inc (OTCMKTS:TBPMF) is one of the leaders in the cannabinoid-based therapeutics sector. Some of...

Whats Hot

CULTIVATING

SHAREHOLDER VALUE

 

Trading Symbol

CSE: CHOO
OTCQB: CHOOF

Choom Holdings Inc. CSE: CHOO | OTCQB: CHOOF